As a clinician-founded company, RapidAI ensures its tools meet practical needs by using curated datasets and advanced image processing techniques. Frost & Sullivan ranks RapidAI's enterprise platform ahead of 96% in the industry. RapidAI is used by more than 2,500 hospitals in over 100 countries and backed by 700+ clinical studies, including research that helped expand national stroke-treatment guidelines.
Cyborg Score Rationale
RapidAI demonstrates exceptional clinical validation, global market penetration, and strategic partnerships. The company has secured $100M in Series C funding and maintains strong competitive positioning with FDA clearances. Near-term growth drivers include AWS partnership (December 2025) and Saudi Arabia deployment (November 2025), though private company status limits financial transparency.
Top Insights
RapidAI's 'deep clinical AI' goes beyond simple triage to localize, quantify, and visualize disease states.
As of March 31, 2026, RapidAI employed 267 people.
Landmark clinical trials using Rapid imaging led to worldwide stroke guidelines expanding the treatment window from 6 to 24 hours.
RapidAI formed a strategic partnership with Health Holdings Company (HHC), Saudi Arabia's largest healthcare provider, to deploy AI across HHC's 20 health clusters (November 2025).
Named Competitors
Viz.ai — AI-enabled care coordination and medical imaging analysis for stroke and acute care
Brainomix — Clinical AI platform for stroke and neurological imaging analysis
Ambra Health — AI-powered medical imaging platform for stroke and acute care workflows
Aidoc — Clinical AI platform for medical imaging detection and prioritization
Subtle Medical — AI imaging analytics for advanced medical imaging workflows
Recent Developments
(December 2025) RapidAI strengthened relationship with AWS to accelerate global adoption, combining AWS's AI infrastructure with RapidAI's clinical expertise and healthcare data.
(November 2025) FDA clearance for five new deep clinical AI modules.
(November 2025) Strategic partnership with Health Holdings Company (HHC) in Saudi Arabia to deploy AI across 20 health clusters.
(April 2026) HCA Healthcare's Good Samaritan Hospital in San Francisco Bay Area became the first facility to deploy RapidAI's Lumina 3D, generating three-dimensional visualizations of blood vessels from CT scans within minutes to accelerate stroke diagnosis.
Open the full interactive RapidAI report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.